Latest Commercialization News

Latrobe Magnesium has locked in a US$2 million non-dilutive prepayment from its US distribution partner to accelerate commissioning of its Demonstration Plant, aiming for first magnesium deliveries in late 2026.

Enlitic has secured a $250,000 data migration contract with St. Jude Children’s Research Hospital, marking its first foray into paediatric healthcare and opening doors for its AI-powered platform Ensight.

Papyrus Australia has commissioned its Adelaide Rapid Prototyping & R&D Facility, marking a key step in validating its pulp technology and progressing towards commercial production. The company also released its interim financials and reported stable cash flow supporting ongoing operations.

St George Mining has partnered with Spain’s Tecnicas Reunidas to test advanced processing technology on its Araxá rare earths, aiming to unlock European markets alongside existing US and Brazilian alliances.

Firebrick Pharma has successfully secured $1.5 million through a strategic placement, positioning itself to accelerate business development and launch new products in key markets.

Jade Gas Holdings has raised A$1.8 million through a well-supported placement to fund the development of Mongolia’s inaugural commercial gas production from the Red Lake gas field. This capital injection positions the company to advance key milestones in its flagship coal bed methane project.

Hastings Technology Metals has acquired a 49% stake in a fully permitted rare earth processing plant in Thailand, aiming to commence production by late 2026. This strategic move offers a lower-cost, near-term production hub with potential to process feedstock from its Yangibana project.

Tamboran Resources has agreed to farm down a significant portion of its Beetaloo Basin acreage to Daly Waters Energy, unlocking a $28.5 million staged earn-in and aligning with a strategic joint venture involving Japan’s INPEX Corporation.

Cyclopharm Limited is rapidly expanding its Technegas® lung imaging technology across the US, securing new contracts and advancing clinical guideline recognition that could boost adoption.

Nexsen Limited's subsidiary has won a HK$6 million grant to accelerate clinical validation and manufacturing of its rapid Group B Streptococcus diagnostic in Hong Kong, positioning the city as a key Asia-Pacific hub.

Temas Resources has commissioned a new metallurgical lab in Ontario to accelerate the scale-up and commercialisation of its innovative Regenerative Chloride Leach (RCL) technology, while securing initial third-party contracts to boost revenue.

Bayan Mining and Minerals has secured membership in the U.S. Defense Industrial Base Consortium, opening doors to strategic partnerships and funding for its rare earth technologies, including a patented yttrium upgrade process. This move positions Bayan at the forefront of efforts to secure critical mineral supply chains vital to U.S. national security.